<DOC>
	<DOCNO>NCT02392104</DOCNO>
	<brief_summary>The purpose study determine feasibility , safety , acceptability implementing extend interval INR follow-up Veterans stable dose warfarin Anticoagulation Clinic William S. Middleton Memorial Veterans Hospital . All participant provide usual care anticoagulation clinic , except interval INRs . If participant continue stable dose warfarin INRs within goal range 2-3 ( include lab variation ) , follow-up visit schedule follow extended interval protocol . Patient satisfaction evaluate various point throughout study . Additionally provider satisfaction , confidence , knowledge extend interval protocol analyze . Bleeding thromboembolic event evaluate ensure safety extend follow-up interval .</brief_summary>
	<brief_title>Prospective Evaluation Extended Interval INR Follow-up VA Anticoagulation Service</brief_title>
	<detailed_description />
	<mesh_term>Warfarin</mesh_term>
	<criteria>18 year age old requirement indefinite warfarin therapy target INR 23 stable weekly warfarin dose past 6 month ( single , onetime adjustment ( boost/omission ) past 6 month , plan interruption procedure surgery INR ( ) range past 6 month would exclude patient ) patient Madison VA anticoagulation clinic previous 12 month consistently drink â‰¥4 alcoholic beverages/day document episode alcohol binge past 6 month diagnosis cancer active chemotherapy/radiotherapy past 3 month life expectancy &lt; 1 year enrol investigational drug protocol receive anticoagulation care Madison VA part year ( e.g . snowbird ) receive visit nurse service INR monitor thrombocytopenia ( &lt; 100K ) within past 12 month history bleed thromboembolism require medical intervention within past 6 month treatment active liver disease ( e.g . hepatitis ) diagnosis documentation EMR suggest cognitive impairment activate power attorney inability provide inform consent nonEnglish speaking unstable mental health disorder impairs judgment history nonadherence anticoagulation clinic policy procedure ( i.e . missed appointment , selfadjustment warfarin dose , nonadherence , etc . ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>International Normalized Ratio</keyword>
	<keyword>Warfarin</keyword>
</DOC>